There was also an interesting finding with the tumour type, with the more aggressive IDC having a lower FGFR2 expression than ILC; patients who had both ILC/IDC components to their carcinomas had FGFR2 levels between IDC alone and ILC alone (Figure 5). The gene discussed is FGFR2; the disease is carcinoma.